CHF Solutions Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Medical Equip
Founded:N/A
Lead Investor(s):Ladenburg Thalmann & Co
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • CHF Solutions's estimated annual revenue is currently $5M per year.
  • CHF Solutions received $5.4M in venture funding in July 2018.
  • CHF Solutions's estimated revenue per employee is $75,758

Employee Data

  • CHF Solutions has 66 Employees.
  • CHF Solutions grew their employee count by -1% last year.
  • CHF Solutions currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Devicix
N/A0N/AN/A
C-Axis and C-Ax...
$17.8M711%N/A
Gemini Medical/...
$19.6M7820%N/A
Urologix
N/A53N/AN/A
Conventus Ortho...
$11.8M479%N/A
Walman Optical
$82.6M3292%N/A
Respicardia
$15.3M6142%N/A
Osprey Medical
$16.8M6718%N/A
Patterson Denta...
$965.1M3845N/AN/A
RespirTech
$64.3M2562%N/A
Missing a competitor? Contribute!?
Submit

CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy. The Aquadex FlexFlow system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's mission is to predict, measure, and control patient fluid balance through science, collaboration, and innovative medical technology. CHF Solutions is a Delaware corporation headquartered in Minneapolis, Minnesota with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.

keywords:Healthcare,Healthcare Providers,Pharmaceuticals

66

Number of Employees

$5M

Revenue (est)

1

Current Jobs

-1%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Audrey SinghSr Director of Clinical ResearchEmail Available
Brad CurrierDirector Of OperationsEmail Available
John ErbChairman and CEO/PresidentEmail Available
Teresa BuechlerAccounting ManagerEmail Available
Harris LewisTherpay Development ManagerEmail Available
Smullen AndrewRegional Sales ManagerEmail Available
Claudia DraytonCFOEmail Available
Joe CiceroTherapy Development ManagerEmail Available
Rich CatalanoSenior Account Manager
Bruce TrittinDirector Strategic AccountsEmail Available

CHF Solutions News

09/03/2019 - CHF Solutions, Inc. Reports Inducement Grants Under ...

EDEN PRAIRIE, Minn., Sept. 06, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that, on September 3, ...

09/04/2019 - CHF Solutions, Inc. Appoints World-Renowned Heart Failure ...

CHF Solutions, Inc. Appoints World-Renowned Heart Failure Cardiologist, Maria Rosa Costanzo, M.D. to Company's Board of Directors ...

09/03/2019 - CHF Solutions (NASDAQ:CHFS) and Vaso (NASDAQ:VASO ...

Vaso (OTCMKTS:VASO) and CHF Solutions (NASDAQ:CHFS) are both small-cap medical companies, but which is the superior investment?

CHF Solutions Funding

DateAmountRoundLead InvestorsReference
2011-07-26$4.6MUndisclosedSummer Street Research PartnerArticle
2011-09-22$7.4MUndisclosedStreet Research PartnersArticle
2013-04-12$13.1MUndisclosedCanaccord GenuityArticle
2015-02-20$10.0MUndisclosedSilicon Valley BankArticle
2016-07-25$3.5MUndisclosedArticle
2017-04-26$9.2MUndisclosedLadenburg Thalmann & CoArticle
2018-07-05$5.4MUndisclosedLadenburg Thalmann & CoArticle

CHF Solutions Executive Hires

DateNameTitleReference
2012-09-14John ErbChairmanArticle
2014-05-07Kimberly OlesonSVP Clinical AffairsArticle
2014-06-17Brian BrownSVP Operations/TechnologyArticle
2015-01-06Claudia DraytonCFOArticle
2016-01-06Eric LovettVP Clinical AffairsArticle
2016-08-17Megan BrandtVP Regulatory Affairs/Quality AssuranceArticle